Full Press Release Details
WATERTOWN, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced that the Company will participate in fireside chats at the following upcoming investor events:
TD Cowen 44th Annual Healthcare Conference in Boston, MA on March 6 at 12:50 p.m. ET;
Leerink Partners Global Biopharma Conference in Miami, FL on March 12 at 3:40 p.m. ET;
Jefferies Biotech on the Bay Summit in Miami, FL on March 13, the Company will host one-on-one meetings only; and
H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference on March 28 at 10:30 a.m. ET.
Live webcasts of the presentations will be available under “News and Events” in the Investors section of the Company’s website at www.kymeratx.com. A replay of the webcasts will be archived and available following the events.
About Kymera Therapeutics
Investor & Media Contact:
Vice President, Investor Relations